Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

709 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany.
Durno N, Arija P, Pantiri K, Heisen M, Boeri M, Paris J, Jack K, Chambenoit O, Subramanian R, Puelles J, Stolk E, van Hout B, Silverberg JI. Durno N, et al. Among authors: silverberg ji. J Dermatolog Treat. 2024 Dec;35(1):2417966. doi: 10.1080/09546634.2024.2417966. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462516 Free article.
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001).
Silverberg JI, Strober B, Feinstein B, Xu J, Guttman-Yassky E, Simpson EL, Li P, Longphre M, Song J, Guo J, Yun J, Williams B, Pan W, Ho S, Collazo R, Wei Z. Silverberg JI, et al. J Allergy Clin Immunol. 2024 Apr;153(4):1040-1049.e12. doi: 10.1016/j.jaci.2023.11.924. Epub 2023 Dec 28. J Allergy Clin Immunol. 2024. PMID: 38157942 Clinical Trial.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. Among authors: silverberg ji. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS).
Silverberg JI, Eichenfield LF, Blauvelt A, Irvine AD, Guttman-Yassky E, Langley RG, Warren RB, French LE, Felding J, Weiss A, Pedersen CB, Jensen ML, Carlsson A, Sommer MOA, Kjøller K, Simpson EL. Silverberg JI, et al. Br J Dermatol. 2025 Jan 7:ljae507. doi: 10.1093/bjd/ljae507. Online ahead of print. Br J Dermatol. 2025. PMID: 39847538
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.
Fonseca DLM, Jäpel M, Gyamfi MA, Filgueiras IS, Baiochi GC, Ostrinski Y, Halpert G, Lavi YB, Vojdani E, Silva-Sousa T, Usuda JN, E Silva JCS, Freire PP, Nóbile AL, Adri AS, Barcelos PM, Corrêa YLG, do Vale FYN, Lopes LO, Schmidt SL, Wang X, Vahldieck C, Fels B, Schimke LF, Cabral-Miranda G, Hirata MH, AKhan TA, Yu YA, Dalmolin RJ, Amital H, Vojdani A, Dias HD, Nakaya H, Ochs HD, Silverberg JI, Zimmerman J, Zyskind I, Rosenberg AZ, Schulze-Forster K, Heidecke H, Catar R, Moll G, Hackel A, Kusche-Vihrog K, Shoenfeld Y, Riemekasten G, Akbarzadeh R, Marques AHC, Cabral-Marques O. Fonseca DLM, et al. Among authors: silverberg ji. NPJ Syst Biol Appl. 2025 Jan 13;11(1):7. doi: 10.1038/s41540-025-00488-z. NPJ Syst Biol Appl. 2025. PMID: 39805853 Free PMC article.
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial.
Simpson EL, Eichenfield LF, Papp KA, Forman SB, Hebert AA, Gonzalez ME, Gooderham MJ, Hong HC, Prajapati VH, Guttman-Yassky E, Silverberg JI, Seal MS, Krupa D, Almaraz E, Hanna D, Burnett P, Snyder S, Chu DH, Higham RC, Berk DR. Simpson EL, et al. Among authors: silverberg ji. Dermatitis. 2025 Jan 10. doi: 10.1089/derm.2024.0418. Online ahead of print. Dermatitis. 2025. PMID: 39792455
709 results